Key result
History of IV anti-hypertensive exposure (aOR 9.30), PO anti-hypertensives at discharge (aOR 4.05), and severe preeclampsia (aOR 2.50) were strongly associated with postpartum ED visits or readmission.
Why the study?
Postpartum hypertension accounts for 15 to 20% of postpartum ED visits and readmissions in the United States, which indicate poor blood pressure control and portend increased morbidity.
What are the risk factors for emergency department visits and readmissions for postpartum hypertension in birthing patients with peripartum hypertension?
Cohort (n=2,403)
No
What are the risk factors for emergency department visits and readmissions for postpartum hypertension in birthing patients with peripartum hypertension?
Odds Ratio: 9.3 (95% CI 6.2–13.95)
p-value: p=<0.001
Maternal age ≥40 years, preeclampsia with severe features, and the need for anti-hypertensive medications are significant risk factors for postpartum ED visits and readmissions for hypertension.
May inform targeted monitoring in high-risk postpartum patients; leaves open whether interventions reduce readmissions.
Objective Postpartum hypertension accounts for 15 to 20% of postpartum Emergency Department (ED) visits and readmissions in the United States. Postpartum readmission is a quality metric and target of quality improvement as it indicates poor control of hypertension and can portend increased morbidity. We aim to evaluate risk factors for postpartum ED visits and readmissions for hypertension.Methods This was a retrospective cohort study of all birthing patients with peripartum hypertension at a single tertiary care center over a 5-year period (2017–2022). Inclusion criteria were age 18 years or above, existing diagnosis of chronic hypertension or hypertensive disease of pregnancy diagnosed during the intrapartum or postpartum course, and both delivery and ED visit or readmission at the study institution. Maternal baseline and intrapartum characteristics were chart abstracted. Primary outcome was ED visit or readmission (EDR) for postpartum hypertension. Patients who had EDR within 42 days of delivery were compared to those who underwent routine outpatient surveillance. For all analyses, p values were two-way, and the level of statistical significance was set at p < 0.05.Results Of 16,162 patients who gave birth during the study period, 2403 (14.9%) patients met the definition of peripartum hypertension. 218 (9.1%) presented to the ED or were readmitted for hypertension. Risk factors for EDR were as follows: maternal age ≥40 years (22.9% vs 15.3%, p = 0.003), prenatal aspirin use (6.9% vs 3.9%, p = 0.039), cesarean delivery (42.7% vs 35.8%, p = 0.044), chronic hypertension (37.2% vs 31.6%, p = 0.029), preeclampsia with severe features (32.6% vs 15.6%, p < 0.001), postpartum hemorrhage (22.9% vs 12.0%, p < 0.001), and intrapartum need for intravenous anti-hypertensives (23.9% vs 3.3%, p < 0.001). Factors at discharge that increased risk of EDR included prescription of anti-hypertensives at discharge (27.5% vs 8.6%, p < 0.001) and having >50% elevated blood pressures within the 24 h prior to discharge (16.5% vs 11.9%, p = 0.046). In a multivariable logistic regression controlling for prenatal aspirin use, mode of delivery, postpartum hemorrhage, and chorioamnionitis, a higher risk of EDR remained for maternal age ≥40 years (aOR, 1.56; 95% confidence interval (CI), 1.11–2.20; p = 0.011), PO anti-hypertensives at discharge (aOR, 4.05; 95% CI, 2.86–5.73; p < 0.001), preeclampsia with severe features (aOR, 2.50; 95% CI, 1.83–3.42; p < 0.001), and history of IV anti-hypertensive exposure (aOR, 9.30; 95% CI, 6.20–13.95; p < 0.001).Conclusions Maternal age of 40 years and above, chronic hypertension, preeclampsia with severe features, prescription of anti-hypertensives on discharge, and elevated blood pressures leading up to discharge are associated with postpartum ED visits or readmissions for hypertension. Risk factor identification can aid in the development of predictive tools to determine high risk groups and interventions to reduce ED visits and readmissions.
No takes yet. Share an insight, caveat, or question.
Mei et al. (2025) conducted a cohort in peripartum hypertension (n=2,403). Risk factors (e.g., IV anti-hypertensive exposure, PO anti-hypertensives at discharge) vs. Absence of risk factors was evaluated on ED visit or readmission (EDR) for postpartum hypertension within 42 days of delivery (aOR 9.30, 95% CI 6.20-13.95, p=<0.001). History of IV anti-hypertensive exposure (aOR 9.30), PO anti-hypertensives at discharge (aOR 4.05), and severe preeclampsia (aOR 2.50) were strongly associated with postpartum ED visits or readmission.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: